Review
Nature Reviews Immunology 4, 878-888 (November 2004) | doi:10.1038/nri1487
Clinical strategies for expansion of haematopoietic stem cells
Brian P. Sorrentino1 About the author
Abstract
Haematopoietic stem cells (HSCs) give rise to all blood and immune cells and are used in clinical transplantation protocols to treat a wide variety of diseases. The ability to increase the number of HSCs either in vivo or in vitro would provide new treatment options, but the amplification of HSCs has been difficult to achieve. Recent insights into the mechanisms of HSC self-renewal now make the amplification of HSCs a plausible clinical goal. This article reviews the molecular mechanisms that control HSC numbers and discusses how these can be modulated to increase the number of HSCs. Clinical applications of HSC expansion are then discussed for their potential to address the current limitations of HSC transplantation.
- View At a Glance
Author affiliations
-
St. Jude Children's Research Hospital, Department of Hematology/Oncology, Division of Experimental Hematology, 332 North Lauderdale, Memphis, Tennessee 38120, USA.
Email: brian.sorrentino@stjude.org
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Leukaemia Niche retreats for stem cellsNature News and Views (14 Dec 2006)
Stem cells Self-renewal writ in bloodNature News and Views (15 May 2003)
RESEARCH
Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic?ischemic ratsJournal of Cerebral Blood Flow & Metabolism Original Article
A role for Wnt signalling in self-renewal of haematopoietic stem cellsNature Article (22 May 2003)
See all 37 matches for Research
